The evidence is growing that biphosphonate drugs, used to treat osteoporosis, may slow the aging process in humans.
Quoted:
“Bisphosphonates were designed to prevent fractures. Scientists are now discovering they may also fight cancer, protect your heart, slow aging at the cellular level—and one of the world’s top aging researchers [Nir Barzilai] just ranked them among his top four longevity drugs.”
“In 2007, something unexpected happened inside a clinical trial at Duke University.
The study was straightforward. Researchers were testing whether a once-yearly infusion of zoledronic acid—a bisphosphonate, a class of drugs designed to strengthen bones—could prevent repeat fractures in patients who had already broken a hip. It could. The drug reduced new fractures by 35%.
But that wasn’t the surprise.
When the researchers tallied the mortality data, they found that patients who received the drug were 28% less likely to die from any cause during the study. Not just from fractures. From anything.
The finding, published in the New England Journal of Medicine, stunned the osteoporosis community. A bone drug—reducing death from all causes? The numbers were so unexpected that the lead investigators initially suspected a statistical error. It wasn’t.
Nearly two decades later, the evidence has only grown stronger. And the implications extend far beyond bone health.”
#biphosphonatesHD #agingHD #longevityHD #osteoporosisHD #osteopeniaHD #boneHD




